Article
Atomic-Resolution Structures of the APC/C Subunits Apc4 and the Apc5 N-Terminal Domain Nora B. Cronin 1, † , Jing Yang 1, 2, † , Ziguo Zhang 1, 2, † , Kiran Kulkarni 1, 3 , Leifu Chang 1, 2 , Hiroyuki Yamano 4 and David Barford 1, 2 1 2 3 4
-
Division of Structural Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, United Kingdom Division of Biochemical Sciences, Council of Scientific and Industrial Research National Chemical Laboratory, Pune 411008, India Cancer Institute, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, United Kingdom
Correspondence to David Barford: Division of Structural Biology, Institute of Cancer Research, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom.
[email protected] http://dx.doi.org/10.1016/j.jmb.2015.08.023 Edited by T. J. Smith
Abstract Many essential biological processes are mediated by complex molecular machines comprising multiple subunits. Knowledge on the architecture of individual subunits and their positions within the overall multimeric complex is key to understanding the molecular mechanisms of macromolecular assemblies. The anaphase-promoting complex/cyclosome (APC/C) is a large multisubunit complex that regulates cell cycle progression by ubiquitinating cell cycle proteins for proteolysis by the proteasome. The holo-complex is composed of 15 different proteins that assemble to generate a complex of 20 subunits. Here, we describe the crystal structures of Apc4 and the N-terminal domain of Apc5 (Apc5 N). Apc4 comprises a WD40 domain split by a long α-helical domain, whereas Apc5 N has an α-helical fold. In a separate study, we had fitted these atomic models to a 3.6-Å-resolution cryo-electron microscopy map of the APC/C. We describe how, in the context of the APC/C, regions of Apc4 disordered in the crystal assume order through contacts to Apc5, whereas Apc5 N shows small conformational changes relative to its crystal structure. We discuss the complementary approaches of high-resolution electron microscopy and protein crystallography to the structure determination of subunits of multimeric complexes. © 2015 MRC Laboratory of Molecular Biology. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction The anaphase-promoting complex/cyclosome (APC/C) is a large multimeric cullin-RING E3 ubiquitin ligase that functions to regulate cell cycle transitions by ubiquitinating specific cell cycle regulatory proteins and targeting them for proteolysis by the ubiquitin-proteasome system [1–5]. In vertebrates, the holoenzyme is a complex of 15 different proteins that assemble into a complex of 20 subunits with a molecular mass approaching 1.2 MDa. Its activity is strictly dependent on the association with the core APC/C of a coactivator subunit (either Cdc20 or Cdh1) that acts both to recruit substrates to the APC/C and to stimulate its E3 ligase catalytic activity [6–15]. Substrate recognition is conferred by
short destruction motifs (D box, KEN box and ABBA motifs [16–19]) that interact with coactivator subunits [7–12]. The core APC/C subunit Apc10 contributes to D box recognition through a D box coreceptor formed with coactivator [13,20,21]. Coactivators increase APC/C activity by promoting an increase in affinity for E2 and by enhancing E2 catalytic efficiency [13–15]. Switching coactivators in late mitosis changes substrate specificities and confers the capacity of the APC/C to ubiquitinate substrates in a cell-cycle-dependent manner. The key role of APC/C Cdc20 is to regulate chromosome segregation in mitosis (reviewed in Refs. [2–5]). APC/C Cdc20 controls the proteolysis of securin and cyclin B, inhibitors of the protease separase (reviewed in Refs. [1–5]). Activated
0022-2836/© 2015 MRC Laboratory of Molecular Biology. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). J Mol Biol (2015) 427, 3300–3315
3301
Atomic-Resolution Structures of Apc4 and Apc5
separase cleaves cohesin, the protein assembly responsible for sister chromatid cohesion. APC/ C Cdh1 in contrast regulates mitotic exit, the events of cytokinesis and initiation of DNA replication. The APC/ C itself controls the switching of Cdc20 and Cdh1 coactivators by regulating the level of cyclin-dependent kinase (CDK)-dependent phosphorylation of core APC/C subunits and Cdh1. Phosphorylation of the APC/C stimulates Cdc20 binding [22,23], whereas Cdh1 phosphorylation negatively regulates its binding to the APC/C [24,25]. A striking feature of the APC/C is its large size. Only four subunits are directly involved in catalyzing protein ubiquitination (the cullin subunit Apc2 and the RING subunit Apc11) [15,26–31] and degron recognition [coactivator subunits (either Cdc20 or Cdh1) and Apc10] [7–13,20,21,32] (reviewed in Refs. [2] and [4]). The remaining 85% of the APC/C mass corresponds to scaffolding subunits, of which seven are large multiple repeat motif proteins (Apc1 and Apc3–Apc8). Four of these are the canonical tetratricopeptide repeat (TPR) proteins Apc3, Apc6, Apc7 and Apc8 that form structurally related homodimers [33–37], whereas Apc1 comprises a proteasome cyclosome repeat domain related in structure to the proteasome cyclosome domain of the proteosomal subunits Rpn1 and Rpn2 [38,39]. Apc5 also includes 13 predicted TPR motifs [40], whereas Apc4 comprises a putative WD40 domain. In addition to coordinating the juxtaposition of the catalytic and substrate recognition modules, scaffolding subunits contribute to catalysis, substrate recognition and regulation. For example, Apc1 and Apc3 incorporate the major CDK-dependent phosphorylation sites [23,41,42] responsible for stimulating Cdc20 association, and in the case of Apc3, these provide docking sites for the Cks subunit of cyclin–CDK–Cks complexes [43]. Through the combination of single-particle cryoelectron microscopy (cryo-EM) of both endogenous and reconstituted complexes with crystallographic analysis and atomic modeling of individual subunits, pseudo-atomic structures of a large proportion of the APC/C have been established. Recently, we reported a 7.4-Å-resolution reconstruction of a ternary complex of human APC/C with the coactivator Cdh1 and a fragment of the high-affinity substrate Hsl1 [13]. This allowed the complete secondary structure assignment of the APC/C and the assignment of all 20 subunits of the complex to their respective segments of the electron microscopy (EM) density map. However, atomic models for Apc4 and the N-termini of both Apc1 (~ 1100 residues) and Apc5 [~ 200 residues (Apc5 N)] were lacking because no crystal structures were available and their homology to proteins of known structure was insufficient to allow the generation of reliable atomic models. Seeking to obtain insights into these structures at atomic resolution and to assist in the interpretation of
cryo-EM reconstructions of the APC/C complex, we determined the crystal structures of full-length Apc4 and the N-terminal domain of Apc5 (Apc5 N ). We docked these atomic models into a 3.6-Åresolution cryo-EM reconstruction of the human APC/C Cdh1.Emi1 complex we had simultaneously determined [44]. Here, we provide a detailed analysis of the crystal structures of Apc4 and Apc5 N and the structures of Apc4 and Apc5 within the context of the whole APC/C. In the complex, regions of Apc4 disordered in the crystal assume order through contacts to Apc5, whereas Apc5 N shows small conformational changes relative to its crystal structure. The Apc4 WD40 domain (Apc4 WD40) is well resolved in the crystal structures but is less well defined in the cryo-EM density map due to its peripheral location in the APC/C. We compare and contrast the differences between the crystallographic and EM densities and highlight the complementary approaches of high-resolution EM and protein crystallography to the structure determination of subunits of multimeric complexes.
Results and Discussion Apc4 is a WD40 repeat protein with an α-helical bundle insert We first determined the crystal structure of Xenopus laevis Apc4 (residues 1–741 that lacked the C-terminal 48 residues that were predicted to be disordered [45]). The protein was overexpressed in the insect cell/baculovirus system and the structure was determined using phases to 3.2 Å resolution derived from multiwavelength anomalous diffraction. Tracing of the polypeptide chain was guided by selenomethionine anomalous signals (Supplementary Table 1). We used the Xenopus Apc4 coordinates to determine the full-length human Apc4 structure to a similar resolution by molecular replacement (Supplementary Table 2). As a result of contacts with Apc5, regions of Apc4, disordered in both the Xenopus and human crystal structures, are defined in the EM density map of the 3.6-Å-resolution cryo-EM reconstruction of human APC/C Cdh1.Emi1 [44] (Supplementary Fig. 1). The human Apc4 crystal structure was fitted into the 3.6-Å-resolution cryo-EM density map of APC/C Cdh1.Emi1 [44] using Chimera [46] (Fig. 1 and Supplementary Fig. 2c). Residues of the Apc4 helical bundle domain HBD (Apc4 HBD ) were well resolved in EM density, and segments of the Apc4 HBD not visible in the crystal structures could be built ab initio into the EM density, allowing an almost complete atomic model to be generated and refined [44] (Supplementary Fig. 1). C-terminal residues (758–808) of human Apc4 are disordered in both the crystal structure and the EM density map. In
3302
Atomic-Resolution Structures of Apc4 and Apc5
a
Apc4WD40 Apc4HBD
b D6 D4/ A5 loop
C6 B6 A5
B5
C5
D5
E5
D4
Apc4WD40
c
Apc4WD40
Apc4
Apc4
Apc4HBD
Apc4HBD
-catenin (M-domain)
-catenin (M-domain)
Fig. 1. Apc4 comprises a WD40 β-propeller toroid split by a helical bundle domain. (a) Cartoon of Apc4 color-ramped from blue to red from N- to C-termini. Shown is the EM structure of human Apc4. (b) Close-up view of the extended blade 5 of Apc4 WD40 and showing the βD4/βA5 loop that blocks access to the mouth of the WD40 domain tunnel. (c) Stereoview showing that the M-domain of α-catenin, superimposed onto the EM structure of human Apc4 HBD, shares structural similarity with the four-helical-bundle domain of Apc4.
contrast, as discussed below, the WD40 β-propeller domain, which is well resolved and ordered in the crystal structures, is less well defined in the EM density, being located at the periphery of the complex (Supplementary Fig. 2b). Apc4 adopts a bi-domain architecture, dominated by a 360-residue seven-bladed WD40 β-propeller domain (Apc4 WD40) split by the HBD (Apc4 HBD) predominantly composed of four long α-helices (Fig. 1a and Supplementary Fig. 1). Apc4 HBD is inserted between strands C and D of blade 4 of the WD40 domain, extending away from the wider lower surface of the β-propeller such that, together, the HBD and WD40 domain generate an L-shaped molecule. A second
smaller insert between β-strands A and B within blade 3 of Apc4 WD40 contacts Apc4 HBD. Finally, an insert between β-strands C and D of blade 6 forms an edge β-strand (βE5) with β-strand D of blade 5 (Fig. 1b and Supplementary Fig. 1). Apart from these three insertions, Apc4 WD40 resembles a canonical β-propeller architecture as judged by its similarity with other WD40 domain proteins (Table 1) (high DALI Z scores [47]). Structure prediction programs were unable to correctly model the β-propeller due to the HBD insert. To our knowledge, the insertion of a helical bundle domain within a WD40 β-propeller domain is novel. The four long α-helices that dominate Apc4 HBD share a structural similarity and antiparallel arrangement with
3303
Atomic-Resolution Structures of Apc4 and Apc5
Table 1. DALI matches (top 3 matches) Search protein Apc5N Apc5TPR Apc4WD40 Apc4HBD
Protein match
PDB
Z
RNP assembly factor Polybromo-1 RBCX protein Malt regulatory protein NPRR Cut9 (Apc6) (8th) Polycomb protein EED WD40 protein eiF3 subunit WD40 protein WDR5 WD40 protein Cytochrome c oxidase Outer surface protein C α-Catenin
3zv0-B 3iu6-A 3q20-A 1hz4-A 4gpk-L 2xpi-A 3iic-A 3zwl-D 2h14-A 1m56-C 1f1m-C 1h6g-A
5.7 4.5 4.5 22.7 18.2 16.1 25.0 24.2 24.0 12.0 10.7 10.7
the four-helix bundle of domain 2 of the M-fragment of α-catenin [48] (Fig. 1c and Table 1). There are extensive contacts between Apc4 HBD and both the bottom surface and the strand surface of the second, third and fourth blades of Apc4 WD40 (Fig. 1a). This packing interaction confers stability to the tertiary structure of Apc4, and small-angle X-ray scattering (SAXS) analysis confirmed that the solution structure is consistent with the X-ray
RMSD (Å)
Nali
Nres
% ID
3.5 3.1 3.4 3.4 5.8 3.7 3.1 3.1 3.1 3.0 2.7 2.7
115 82 77 325 320 340 312 285 280 129 133 129
329 143 114 366 346 520 357 352 303 265 162 255
10 7 10 12 9 12 10 10 12 4 11 6
structure (Supplementary Fig. 2c). Moreover, superimposing the Apc4 model from the crystal structure onto the EM-derived structure [44] showed that, except for the ordering of regions of Apc4 HBD, the conformation of Apc4 does not change in the context of the APC/C, indicating that the HBD and WD40 domains are rigidly associated (Fig. 2a and b). Human and X. laevis Apc4 are also very similar, differing only for residues 120–130 (X. laevis Apc4
a
b
Apc4Xray Apc4EM
Apc4Xray Apc4EM
6! 9
6 3
6! 6 3
11
5 4
11
5 4
7
7
9
8
Apc4HBD
8 10
10
Apc5TPR
Apc5N
c Apc4Hs Apc4Xl
Apc4Hs Apc4Xl
3
11
3
8
11
8 7
Apc4HBD
7
6 Apc4Xl -helix
Apc4HBD
6 Apc4Xl -helix
Fig. 2. The Apc4–Apc5 protein interface orders regions of Apc4 HBD. (a) Human Apc4–Apc5 as organized in the APC/C with the X-ray structure of Apc4 (red) superimposed onto the EM coordinates (brown). The Apc4–Apc5 interface is shown. (b) As in (a) but without Apc5. (c) Stereoview showing that the crystal structures of X. laevis and human Apc4 are very similar (RMSD is 2.1 Å).
3304
Atomic-Resolution Structures of Apc4 and Apc5
numbering) within the shorter WD40 insert that is an α-helix in the X. laevis Apc4 structure in contrast to a predominantly disordered loop structure in human Apc4 (Fig. 2c and Table 2). Conformational changes of Apc4 from the crystal structures in the context of the whole APC/C Overall, the crystal and EM structures of Apc4 differ by an RMSD of 2.5 Å (Fig. 2a and Table 2). Differences between the Apc4 crystal and EM structures relate primarily to the tip of Apc4 HBD . These involve conformational changes and creation of new α-helices. In the context of the APC/C, due to interactions with Apc5, regions of Apc4 that are disordered in the crystal structures adopt ordered α-helical conformations (α4, α9 and α10) (Fig. 2a and b). Helix α4, located at the end of Apc4HBD, forms specific contacts to Apc5 N, whereas α10 becomes ordered due to packing against the TPR domain of Apc5 TPR. Ordering of the tip of Apc4 HBD induces a 45° bend toward the C-terminus of α3, a smaller bend of α6, a shift and extension of α5 and repositioning of α8. Finally, α9 forms to connect α8 with α10. Figure 3 shows a comparison of the EM density and X-ray (2Fo − Fc) maps of human Apc4, determined to similar resolutions, 3.6 Å and 3.4 Å, respectively. In the EM density map, secondary structural features are well defined, whereas secondary structural elements at the tip and periphery of Apc4 HBD that are resolved in the EM density map are disordered in the X-ray structure (α4, α9 and α10). For both EM and X-ray maps, within the core of Apc4 HBD, amino acid sidechain densities are of comparable quality, allowing ab initio fitting of the polypeptide sequence (Fig. 4). In contrast, whereas the X-ray map shows wellresolved side-chain densities for residues of Apc4 WD40 (Fig. 5a), in the EM map, these side chains are poorly defined, particularly for residues of Apc4 WD40 at the periphery of the APC/C, for example, blades 5 and 6 (Fig. 5b). Thus, regions of Apc4 that assume order only in the context of their interaction with the neighboring Apc5 subunit of the APC/C are visible in the EM map. Apc4 WD40 is less well defined in the EM map due to its location at the periphery of the molecule where it engages in few intersubunit contacts (Supplementary Fig. 2b), and EM maps have the largest alignment inaccuracies. Additionally, structural variability due to relative intersubunit rotations may be amplified at the periphery of the molecule. In the human Apc4 crystal,
Apc4 WD40 is secured through lattice contacts with two neighboring molecules (data not shown). Apc5 is a TPR protein with an N-terminal α-helical domain Bioinformatics analysis of Apc5 had previously identified Apc5 as a variant TPR protein comprising 13 contiguous TPR-like motifs (residues 206–740), C-terminal to a small α-helical domain [40]. Whereas the canonical TPR is a 34-amino-acid motif [49,50], in Apc5, the repeat varies in length from 34 to 40 amino acids. However, consistent with a TPR protein, the consensus TPR residues (small aliphatic at positions 8, 20 and 27; larger aliphatic residues at positions 1, 4, 7, 10, 24 and 28) [49] are present in Apc5 TPR motifs [40]. Residues 1–208 N-terminal to the TPR domain do not conform to a TPR consensus sequence and no repeat motif was detected using TPRpred [51] and HHrep [52]. Based on secondary structure prediction (Phyre2 [53]) and structure disorder programs (OnD-CRF [45]), residues 1–160 were predicted to be ordered and α-helical, with a disordered linker of ~ 30 residues connecting this helical domain to the TPR domain. We purified residues 1–161 of X. laevis Apc5 as a bi-product of the Apc4–Apc5 N coexpression system and crystallized the protein. The structure was determined to 2.2 Å resolution using single-wavelength anomalous diffraction phasing (Supplementary Table 2). Apc5 N [residues 27–161 (human Apc5 numbering)] adopts an all α-helical domain architecture comprising seven α-helices (Fig. 6a and Supplementary Fig. 6). Helices α1–α6 pack to create an antiparallel bundle with α1 at the center of the domain almost completely surrounded by helices α2–α6. This α-helical domain is capped by α7, orientated orthogonally to the α-helical domain. The X-ray structure of X. laevis Apc5 N was readily docked into the assigned density of the 3.6-Å-resolution EM density map of human APC/C Cdh1.Emi1 [44] (Supplementary Fig. 2a). A small shift of the loop connecting α5 with α6 accommodates the Apc4–Apc5 interface within the context of the APC/C (Fig. 6b). A larger 6-Å-conformational change involving the loop connecting α1 with α2 and the N-terminus of α2 results from both packing at the Apc4–Apc5 interface and a two-residue insertion within human Apc5 relative to X. laevis Apc5 (Supplementary Fig. 3). Residues 1–26 of Apc5 N, predicted to form two α-helices, are disordered
Table 2. RMSD of Apc4 and Apc5 X-ray and EM models Subunit EM
H.s. Apc4 H.s. Apc4X-ray H.s. Apc5EM
H.s. Apc4EM
H.s. Apc4X-ray
X.l. Apc4X-ray
X.l. Apc5X-ray
— — —
2.4 Å — —
2.5 Å 2.1 Å —
— — 2.0 Å
Atomic-Resolution Structures of Apc4 and Apc5
3305
a
b
Fig. 3. Comparison of EM density maps of APC/C Cdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4. (a) Stereoview of the EM density map and Apc4 coordinates. Main chain is shown as a cartoon. (b) Stereoview of the 2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is shown as a cartoon.
in both the crystal structure and the EM density map. No EM density is visible for the loop (residues 170– 205) connecting Apc5 N with Apc5 TPR, and thus, as predicted, this loop is disordered. In the crystal structure, residues 164–168 from the TEV cleavage site continue the α7 helix, similar in structure to α7 of human Apc5 N defined in the EM density map. DALI searches [47] revealed weak structural similarity to the RNP assembly factor (Table 1), although the biological significance of this similarity is unclear. Supplementary Figure 4 shows a comparison of the EM density and X-ray (2Fo − Fc) maps of human Apc5 and Xenopus Apc5 N. The maps determined to resolutions of 3.6 Å and 2.2 Å, respectively, show clear differences in structural detail, although side chains are well resolved in both maps. Trp29 of Apc5 N adopts different rotamer conformations in the two structures. The “outward”-facing conformer observed in the crystal structure is hindered in the context of the APC/C due to the close proximity of Apc5 TPR. A model for Apc5 TPR was derived using the TPR superhelix of Schizosaccharomyces pombe Apc6 comprising 14 contiguous TPR motifs [35] as a template using Phyre2 [53]. The 3.6-Å-resolution EM density map of human APC/C Cdh1.Emi1 was of sufficient quality to fit extended TPR α-helices and model residue side-chain conformations (Supplementary Fig. 2a), resulting in a refined atomic model [44] (Fig. 6a). Except for some instances of longer TPR α-helices, Apc5 TPR conforms well to a canonical TPR superhelix, adopting a similar pitch of seven
TPR motifs per TPR superhelical turn [49]. Apc5 TPR matches most closely with the MALT regulatory protein (DALI Z score of 23) (Table 1 and Supplementary Fig. 5a). The TPR superhelices of Apc5 and Apc6 are also similar (DALI score of 16) (Table 1 and Supplementary Fig. 5b). The N-terminus of the TPR superhelix is stabilized by the extended N-terminus of the TPR-accessory subunit Apc15 that lines the internal groove of the TPR superhelix (Fig. 6a), reminiscent of Apc12 interactions with the C-terminal superhelical turn of Apc6 [33,35]. The C-terminal 13 residues of Apc5 fold back into the TPR superhelix, and this segment of Apc5, together with the N-terminus of Apc15, encloses a cavity within the C-terminus of Apc5 TPR . A 24-residue segment of Apc1 caps the C-terminus of Apc5 TPR (Fig. 6a). Apc5 N and Apc5 TPR domains do not interact directly, and the overall structure of Apc5 is dependent on its extensive interface with Apc4 (Figs. 2a and 7a and b). The absence of direct interactions between Apc5 N and Apc5 TPR likely accommodates the conformational change within the APC/C platform that is associated with Cdh1 binding and the stimulation of APC/C activity [13]. Apc4 and Apc5 interact through Apc4 HBD and Apc5 TPR Apc4 and Apc5 form extensive and stable interactions, burying 6226 Å 2 (Figs. 2a and 7a and b and Table 3). A heterodimer of Apc4 and Apc5 is isolated as a bi-product of the reconstitution of the apo-APC/
3306
Atomic-Resolution Structures of Apc4 and Apc5
a
b
Fig. 4. Comparison of EM density maps of APC/C Cdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4 HBD. (a) Stereoview of the EM density map and Apc4 coordinates. Main chain is shown as a cartoon, and amino acid side chains are shown as sticks. (b) Stereoview of the 2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is shown as a cartoon, and amino acid side chains are shown as sticks.
C (yeast and human) [40,54] and the two proteins can be stably coexpressed (this work and Ref. [40]). The isolation of an Apc4–Apc5 N complex indicates that Apc5 N itself interacts with Apc4, consistent with the APC/C structure [44]. However, the tendency of this complex to dissociate during purification indicates that Apc5 TPR is required to maintain stable Apc4–Apc5 interactions. At the Apc4–Apc5 interface, the Apc5 TPR superhelix packs colinear with Apc4 HBD, with Apc5 N packing against the tip of Apc4 HBD (Figs. 2a and 7a and b). The similar size of Apc4 HBD and Apc5 TPR results in a complementary interface between the two proteins. Conserved surfaces of both subunits comprise the Apc4–Apc5 intersubunit interface (Fig. 7a and b). A stable Apc4 and Apc5 heterodimer suggests the possibility that it exists as an intermediate subcomplex on the APC/C assembly pathway. Apc4 and Apc5 interactions with other APC/C subunits Apc4 WD40 contacts the N-terminal cullin repeat domain of Apc2. The interaction involves a conserved
edge of the β-toroid of Apc4 WD40 (Fig. 7a and Supplementary Fig. 2b and Table 3). Common interacting surfaces of WD40 domains are entry mouths to the central tunnel. In Apc4 WD40 of APC/C Cdh1.Emi1, these are exposed [44] (Fig. 7a–c and Supplementary Fig. 2b) and that on the lower surface of the domain is 45 Å in diameter, typical of sevenbladed β-propeller proteins. However, in Apc4 WD40, a tunnel through the β-toroid is blocked by the interstrand loop that connects βD4 and βA5 (Fig. 1b). Complexes of APC/C Cdh1 with UbcH10 (the initiating E2 for human APC/C) showed that contacts to the backside of UbcH10 rigidify the WHB domain of Apc2 (Apc2 WHB) [30]. This interaction enhances both APC/ C–UbcH10 affinity and UbcH10 catalytic activity [30]. Examination of the APC/C Cdh1.Hsl1–UbcH10 cryo-EM map [44] revealed EM density linking Apc2 WHB with Apc4 WD40, specifically the small insertion associated with blade 3 (Fig. 7d). This interaction may reinforce the position of Apc2 WHB , facilitating contacts to UbcH10, thereby contributing to the substantially increased affinity of UbcH10 for the APC/C relative to an isolated Apc2–Apc11 heterodimer, even though UbcH10 only contacts Apc2 and Apc11 [30,44].
Atomic-Resolution Structures of Apc4 and Apc5
3307
a
b
Fig. 5. Comparison of EM density maps of APC/C Cdh1.Emi1 and crystal structure 2Fo − Fc maps of human Apc4 WD40. (a) Stereoview of the 2Fo − Fc density map contoured at 1σ and Apc4 coordinates. Main chain is shown as a cartoon, and amino acid side chains are shown as sticks. (b) Stereoview of the EM density map and Apc4 coordinates. Main chain is shown as a cartoon, and amino acid side chains are shown as sticks.
In addition to its interface with Apc4, Apc5 forms further extensive interfaces with Apc1, Apc8 and Apc15 (Fig. 7 and Supplementary Fig. 2b and Table 3). All three domains of Apc1 (Apc1 WD40, Apc1 Mid and Apc1 PC) interact with Apc5 TPR. The most substantial contacts are contributed by Apc1 WD40 and Apc1 Mid, with the edge of Apc1 WD40 inserting into the groove of the Apc5 TPR superhelix (Fig. 7b). The Apc8 homodimer bridges Apc5 N and Apc5 TPR (Fig. 7b and c). As described above, the N-terminal segment of Apc15 (residues 1–25) inserts into the superhelix of Apc5 TPR, whereas residues 26– 46 of Apc15 form an α-helix that bridges Apc5 N with Apc8A (Fig. 7c). Cryo-EM and X-ray crystallography provide complementary information on multiprotein complex structures A comparison of crystal structures of individual subunits with their conformations in the context of multimeric complexes allows an analysis of the extent of conformational changes resulting from multiple intersubunit interactions. For the APC/C, regions of Apc4 that are disordered in isolation become ordered and stabilized as a result of intersubunit contacts with
Apc5 (Figs. 2a and 3). However, the side chains of Apc4 WD40, which are well defined in the crystal structure, are less well defined in the cryo-EM map (Fig. 5). To obtain insights into how the other APC/C subunits become ordered through interactions with neighboring subunits in the context of the APC/C, we tabulated regions of disorder of APC/C subunits as observed in crystal structures for comparison with disordered regions of the APC/C (Table 4). This analysis is complicated by the fact that crystallizable proteins often have disordered regions, either defined as being proteolytically sensitive or predicted to be disordered, removed prior to crystallization. However, where data are available, with the exceptions of the C-terminal segments of Apc10 and Cdh1 (discussed below) and Apc4 noted above, there is a good correlation between disordered regions of APC/C subunits observed in crystal structures and in the APC/C, for example, the C-terminal 50–60 residues of Apc3, Apc4 and Apc12, and the N-terminal 26 residues of Apc5. In contrast to their crystal structures, the C-terminal ~ 20 residues of Apc10 and Cdh1 are ordered in the APC/C due to the interaction of their C-terminal IR (Ile-Arg) motifs with the IR tail-binding sites of Apc3 [44]. This suggests that, for
3308
Atomic-Resolution Structures of Apc4 and Apc5
a Apc15
6
Apc5N
5
N
N
C
2
1 4
3 7
Apc5TPR
Apc5N-Apc5TPR linker
b
Apc4 5
Apc1
Apc4 5
3
7
3
7 4
8
Apc5N(EM)
Apc5N(Xray)
4
8
Apc5N(EM)
Apc5N(Xray)
Fig. 6. Apc5 has an N-terminal helical domain (Apc5 N) connected by a disordered linker to a TPR superhelix of 13 TPR motifs (Apc5 TPR). (a) Cartoon of EM structure of human Apc5 color-ramped from blue to red from N- to C-termini. The small subunit Apc15 that contacts Apc5 is also shown. (b) Stereoview of a superimposition of Apc5 N based on human Apc5 N EM coordinates (blue) and Xenopus Apc5 N X-ray (yellow) coordinates. Major structural differences involve the α1/α2 and α5/ α6 loops that contact Apc4.
the subunits analyzed, protein–protein interfaces are mediated primarily through globular domains. However, we note that the small intrinsically disordered proteins Apc13 and Apc16 (for which there are no or little crystallographic or NMR data) adopt nonglobular structures and mediate numerous intersubunit interactions in the context of the APC/C. Similarly, specific insertions predicted as disordered within the large globular subunits Apc1 and Apc2, for which no crystal structures exist, also mediate intersubunit interactions. We have noted that, due to its position at the periphery of the complex, the EM density of Apc4 WD40 is less well defined than that for more ordered centrally located subunits (Supplementary Figs. 2b and 6) [44]. Thus, interpretation of the Apc4 WD40 cryo-EM density of APC/C Cdh1.Emi1 was guided by the Apc4 crystal structure. Some other peripherally located domains and subunits of the APC/C are also defined at resolutions sufficient for definition of secondary structures (e.g., at 5–7 Å) but lower than that required for unambiguous side-chain definition [44] (Supplementary Fig. 6). Interpretation of the EM densities corresponding to these regions of the APC/C relied
on existing atomic models from crystal structures and homology modeling. These include the WD40 domain of Cdh1 (Cdh1 WD40) [18], the catalytic module of Apc2 CTD [55] and Apc11 [31] and Apc7 [56]. The catalytic module and Cdh1 WD40 participate in few contacts to neighboring subunits, and thus, their intrinsic flexibility results in structural variability with concomitant lower resolution in EM density maps. This study illustrates the complementarity of X-ray crystallography and EM approaches to the structure determination of multimeric complexes.
Materials and Methods Apc4 and Apc5 N cloning, expression, purification and crystallization Overview of methods Expression and purification of the human APC/C complex (tagged on Apc4) [54] yielded together with APC/C free Apc4 as identified by mass spectrometry. Initial crystals of Apc4 were obtained using the PACT
3309
Atomic-Resolution Structures of Apc4 and Apc5
a Apc2
Apc2
Apc5TPR
Apc5TPR Apc4WD40
Apc15
Apc5N
Apc4HBD
Apc11
b
Apc5N
Apc4WD40
Apc4HBD
Apc15
Apc11
c
Apc8A
Apc8A Apc4
Apc5N
Apc4
Apc4WD40
Apc5TPR
Apc15 Apc5N
Apc5TPR
Apc1Mid
Apc8B
Apc1WD40
d
Apc1
Apc1
Apc8B Apc1PC
Apc11 Cdh1 UbcH10 Apc2 Apc15 Apc2WHB
Apc2WHB-Apc4WD40 insert interface
Apc5
Apc4WD40
Fig. 7. Apc4 and Apc5 interact with neighboring subunits through evolutionarily conserved protein–protein interfaces. (a) Surface of Apc4 color-coded according to conservation (purple, conserved; cyan, unconserved). Contacting subunits Apc2, Apc5 and Apc15 are shown as cartoons. (b and c) Surface of Apc5 color-coded according to conservation (purple, conserved; cyan, unconserved). Contacting subunits Apc1, Apc4, Apc8 and Apc15 are shown as cartoons. (d) Cryo-EM density map of the APC/C Cdh1.Hsl1–UbcH10 complex, color-coded according to subunit assignments [44]. Density connects Apc2 WHB with the blade 3 insert of Apc4 WD40, suggesting a direct interaction between these domains. EM coordinates are shown. Table 3. Intersubunit solvent-accessible surface area (Å 2) Subunit Apc4 Apc5
Apc4
Apc5
Apc1
Apc2
Apc8
Apc15
— —
6226 —
0 8744
714 0
0 3772
0 3446
Data taken from Ref. [44].
crystallization screen, which were then optimized. Expression of Apc4 together with Apc5 and Apc15 from human, X. laevis, Saccharomyces cerevisiae and S. pombe was performed. An Apc4–Apc5 complex was expressed and purified from all four species. However, attempts to crystallize human and S. cerevisiae Apc4–Apc5 were unsuccessful. We also determined that the N-terminus of
3310
Table 4. Table comparing regions of disordering in APC/C subunits as observed from X-ray structures and the cryo-EM structure of APC/C Cdh1.Emi1 Subunit —
X-ray structure
EM structure. PDB code 4UI9. H.s. APC/C. Ref. [44]
Disorder prediction
H.s. amino acids (N)
PDB code
Ref.
Construct
Disordered regions within crystal
Disordered regions
—
—
H.s. Apc3
4RG6
[37]
1–181, 454–830 (830)
5BPW
This study
1–808 (808)a
171–450, 767–830 (A)b 171–450, 782–830 (B) 429–438, 458–469, 758–808
X.l. Apc5
5BPZ
This study
1–163 (759)
H.s. Apc6
3YUM
[33]
212–539 (620)
212–228, 530–539
S.p. Apc6 H.s. Apc7
2XPI 3FFL
[35] [56]
1–597 (671) 1–147 (599)
1–44, 61–80, 596–597 1–20, 77–96, 147
S.p. Apc8
3ZN3
[34]
19–302 (565)
57–77, 136–151, 285–292
H.s. Apc10 H.s. Apc11 H.s. Apc12 S.p. Apc12 H.s. Apc16 S.c. Cdh1
1JHJ 4R2Y 3YUM 2XPI 4RG6 4BH6
[70] [31] [33] [35] [37] [39]
1–185 (185) 17–84 (84) 1–85 (85) 1–80 (80) 74–110 (110) 241–550 (566)
163–185 17–20 27–85 25–80 108–110 1–4, 549–550
96–126, 528–620 (A) 96–123, 534–620 (B) As above 1–35, 111–131, 553–599 (A) 1–35, 111–131, 541–599 (B) 1–25, 501–508, 558–597 (A) 1–25, 501–508, 558–597 (B) None None 26–85 As above 1–51 1–41, 68–87, 109–124, 133–145, 164–168, 471–482
1–7, 94–109, 172–453, 770–830 1–9, 125–164, 557–570, 753–808 1–8, 166–212, 284–298, 741–755 1–12, 110–130, 546–620 As above 1–8, 60–71, 98–140, 534–599 1–10, 125–167, 571–597 1–28, 180–185 None 1–9, 25–85 As above 1–53, 94–110 1–93, 131–146, 152–172, 490–496
830
H.s. Apc4
1–4, 172–181, 768–830 1–5, 304–317, 431–444, 458–472, 479–521, 758–808 1–26
b
Numbers in parentheses indicate protein residue number. Letters in parentheses indicate subunit label.
755 620 As above 599 597 185 84 85 As above 110 496
Atomic-Resolution Structures of Apc4 and Apc5
a
1–26, 170–205
808
3311
Atomic-Resolution Structures of Apc4 and Apc5 Apc5 (residues 1–163) (Apc5 N) interacts with Apc4 by coexpressing Apc4 and Apc5 N. This coexpression yielded a huge increase of protein amounts for human, X. laevis, S. cerevisiae and S. pombe. X. laevis Apc4–Apc5 N was crystallized, but diffraction was limited to 8 Å resolution. After deleting the predicted unstructured C-terminal residues 742–789 of Apc4, we purified the X. laevis Apc4–Apc5 N complex and we isolated Apc4 and Apc5 N proteins from a single purification. All of these crystallized. Apc4 and Apc5 N crystals were finally optimized for structure determination (see below). The X. laevis Apc4 crystal structure was used as a search object to determine the full-length human Apc4 crystal structure by molecular replacement. Cloning, expression, purification and crystallization To clone X. laevis Apc4 and the Apc5 N-terminal domain, we amplified and modified Apc4 1-741 and Apc51-163,E163D (Apc5N) gene fragments by PCR from X. laevis Apc4 and Apc5 cDNA clones and cloned them into pU1 plasmid as previously described [54]. A double StrepII tag together with a TEV cleavage site was attached to the C-terminus of Apc5 N. The proteins were expressed in the insect cell baculovirus system. Protein expression with selenomethionine labeling was performed in High 5 cells by a protocol modified from Ref. [57]. In brief, 16 h post-infection, cells from a 3.5-L culture were spun at 300g for 15 min at 22 °C, the supernatant was discarded and the cells was resuspended in 2.5 L of cysteine- and methionine-free Sf900II SFM media with 150 mg/L of L-cysteine. After starving the cells for 6 h, the media was replaced with 3.5 L of cysteineand methionine-free Sf900II SFM media with 150 mg/L of L-cysteine and 250 mg/L of L-selenomethionine (Molecular Dimensions MD12-503). The cells were incubated under the same conditions and were harvested for protein purification 18 h post-selenomethionine addition. X. laevis Apc4 1 -741 (now referred to as X. laevis Apc4) was purified by collecting the late fractions of the StrepTactin (Qiagen) wash step and was further purified by anion-exchange chromatography Mono Q (GE Healthcare) and Superdex 200 size-exclusion chromatography (GE Healthcare). Selenomethionine-labeled Apc4 was purified as for the native protein except for the addition of 10 mM DTT and 5 mM ethylenediaminetetraacetic acid (EDTA) in the buffer. The selenomethionine labeling was confirmed by mass spectrometry. Xenopus Apc5 N was purified using a combination of Strep-Tactin, TEV cleavage, Mono Q anion-exchange chromatography, a Ni-NTA column to trap TEV and Superdex 75 size-exclusion chromatography. To crystallize X. laevis Apc4, we concentrated the protein to 3.5 mg/mL in a buffer of 20 mM Hepes (pH 8.0), 200 mM NaCl and 2 mM DTT. Initial crystals were obtained by vapor diffusion in sitting drop in a buffer containing 0.1 M sodium citrate 5.0, 8% (w/v) polyethylene glycol (PEG) 8000. By seeding with the initial crystals, we grew large crystals in a buffer containing 0.1 M sodium citrate 5.0, 3% (w/v) PEG 8000, 250 mM magnesium acetate, 10 mM Tris–HCl (pH 8.5), 200 mM NDSB 211, 4% (v/v) ethylene glycol and 2 mM DTT. Crystals were cryoprotected in the same buffer with addition of 30% (v/v) glycerol prior to freezing in liquid nitrogen. To crystallize X. laevis Apc5 N, we concentrated the protein to 3.4 mg/mL. Plate-like crystals were grown in a
buffer containing 40 mM sodium propionate, 20 mM sodium cacodylate, 40 mM 2-[bis(2-hydroxyethyl)amino]-2(hydroxymethyl)propane-1,3-diol (Bistris) propane (pH 7.0) and 25% (v/v) PEG 1500. Larger crystals were obtained by seeding. For heavy metal labeling, we soaked crystals with 10 mM KAu(CN)2 or 1 mM ethylmercury p-toluene sulfonamide in a buffer containing 20 mM Hepes, 200 mM NaCl, 40 mM sodium propionate, 20 mM sodium cacodylate, 40 mM Bistris propane (pH 7.0) and 25% (v/v) PEG 1500 for 1 h before being harvested in the same buffer with addition of 15% (v/v) glycerol. Human Apc4 was purified as a bi-product from the APC/ C expression system [54]. The protein was purified using a combination of Strep-Tactin, Mono Q anion-exchange chromatography and Superdex 200 size-exclusion chromatography. The protein was concentrated to 4 mg/mL in a buffer containing 20 mM Hepes (pH 8.0), 150 mM NaCl and 1 mM DTT. Initial crystals were obtained by vapor diffusion in a buffer containing 20 mM sodium propionate, 10 mM sodium cacodylate, 20 mM Bistris propane (pH 9.0) and 25% (v/v) PEG 1500. Seeding with the initial crystals, we grew human Apc4 crystals by vapor diffusion in a buffer containing 10 mM malic acid, 20 mM Mes, 20 mM Tris–HCl (pH 8.0), 160 mM NDSB 196, 10 mM EDTA and 19% (v/v) PEG 1500. Crystals were incubated in a cryoprotection buffer comprising 10 mM malic acid, 20 mM Mes, 20 mM Tris–HCl (pH 8.0), 160 mM NDSB 196, 10 mM EDTA, 22% (v/v) PEG 1500 and 20% (v/v) ethylene glycol prior to freezing in liquid nitrogen. Data collection and processing X. laevis Apc5 N The diffraction data for the native crystal were collected to a resolution of 2.2 Å on I04 beamline at Diamond Light Source. Derivative data were collected on beamline I24 for a crystal soaked in 10 mM KAu(CN)2 for 30 min at the gold L-III edge energy of 12.031 keV and a crystal soaked in 1 mM ethylmercury p-toluene sulfonamide for 30 min at the mercury L-III edge energy of 12.299 keV to a resolution of 2.4 Å. Data were processed and scaled using Xds [58] and the CCP4 program Aimless/TRUNCATE [59], respectively. The derivatives were scaled to the native and the mean empirical ratios between the anomalous and isomorphous differences, and Kemp [(F +PH − F −PH)/FPH − FP] was 5.65 for the gold and was 5.56 for the mercury data. X. laevis Apc4 Several native and heavy-atom derivative datasets were collected and phasing attempts yielded reasonable phases. However, selenomethionine derivative data gave optimum phases with interpretable maps and were finally used to determine the structure. Data were collected on the Diamond Light Source I24 beamline using the defocused beamsize of 20 μm × 20 μm. The crystal morphology of long needles facilitated a line-scan data collection strategy. Data were collected on the Se-edge peak energy of 12,663 eV and three datasets from two crystals were combined generating a 3.8-Å-resolution peak dataset. On a later visit to I24, a high-energy remote dataset was collected on a selenomethionine derivative crystal to 3.2 Å resolution. These two datasets were
3312 scaled using SCALEIT [59] and the mean empirical ratio between the anomalous and dispersive differences, Kemp [(F +PH − F −PH)/FPH − FP] was 4.0 for the peak and high remote datasets. Human Apc4 Needle-like tiny crystals were found to be extremely radiation sensitive. Hence, diffraction data were collected from a large number of crystals on the microfocus beamline I24 of Diamond Light Source. With the inspection of Rmerge and I/σ(I) of all the collected data, datasets from four crystals were indexed, merged and scaled with Xds [58] and SCALEIT [59]. Structure determination and refinement Apc5 N Heavy-atom detection, refinement and phasing were carried out using MIRAS with two derivatives in autoSHARP [60]. The positions and identities of three sites for each derivative along with the observed anomalous differences, isomorphous differences and structure factors were input for heavy-atom parameter refinement and phasing to autoSHARP. The data were subjected to 28 cycles of solvent flipping with the program SOLOMON. Automatic building was carried out using ARP/wARP giving an initial model with Rwork of 0.27 (Rfree = 0.34) after a cycle of REFMAC [61]. TLS refinement and rebuilding were carried out using REFMAC [61] and Coot [62] and to yield a model with Rwork/Rfree of 0.20/0.24. X. laevis Apc4 Heavy-atom detection, refinement and phasing were carried out using a two-wavelength anomalous diffraction strategy in autoSHARP [60]. The positions of 14 selenomethionine sites were determined, and together with the anomalous differences, the dispersive differences and structure factors were input to SHARP for heavy-atom site refinement and phasing. The data were subjected to 28 cycles of solvent flipping with the program SOLOMON. Several cycles of PARROT density modification that uses an MLHL-type likelihood target function and BUCCANEER that is optimized for tracing protein chains at low resolution with good phases gave an initial model with an Rwork of 0.46 (Rfree = 0.44). Extensive cycles of manual model building and refinement with PHENIX [63] and REFMAC [61] were performed. Human Apc4 Phases were obtained from molecular replacement using X. laevis Apc4 as a search model, employing PHASER [64]. Electron density maps obtained from solvent flattening, using DM [59], were used for initial model building. Iterative cycles of manual model building and refinements were performed using Coot [62] and PHENIX [63], respectively. To check for model bias, we systematically calculated simulated annealing composite omit maps at various stages of model building and
Atomic-Resolution Structures of Apc4 and Apc5
refinement. The refined structure was validated with MolProbity [65]. Structure analysis Evolutionary-conserved surfaces were determined using ConSurf [66]. Figures were generated using PyMOL ‡. Regions of disorder in Apc4 and Apc5 were predicted using OnD-CRF § [45]. TPR predictions were performed using TPRpred || and HHrep ¶ [51,52]. Protein structure predictions were performed using Phyre2 protein recognition server a [53]. SAXS data collection and data analysis Apc4 was concentrated to approximately 20 mg/mL. SAXS data were collected at the SWING beamline (Synchrotron Soleil, Paris, France). The beamsize was 400 μm × 100 μm, the beam energy was 12.4 keV and the flux was approximately 10 12 photons per second. The images were collected using the AVIEV170170 CCD detector and the SAXS cell-to-detector distance was 1892 cm. The samples were loaded in gel-filtration buffer using an online HPLC device and a Shodex_KW402.5-4F size-exclusion column. The column and flow cell were maintained at 10 °C and the sample holder prior to injection was at 4 °C. Data were processed using the beamline software FOXTROT and Guinier analysis was performed using PRIMUS [48]. Theoretical SAXS profiles for Apc4 were calculated and fitted to the SAXS experimental profiles with the FoXS Web server [67]. Radius of gyration (Rg) were determined from the experimental SAXS profile using GNOM [50] and calculated Rg using FoXS. X-ray crystallographic maps and EM density maps were displayed and analyzed using Coot [62] and PyMOL. Atomic models were docked into the APC/C Cdh1.Emi1 cryo-EM map [44] using Chimera [46]. Local-resolution EM maps were calculated using ResMap [68]. Accession numbers Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 5BPW, 5BPT and 5BPZ for human and Xenopus Apc4 and Xenopus Apc5 N, respectively.
Acknowledgements We thank staff at Diamond Light Source beamlines I04 and I24 for help with data collection. The work was funded by a Cancer Research UK grant (C576/ A14109) to D.B. and by a Marie Curie Cancer Care grant to H.Y.
Appendix A. Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jmb.2015.08.023.
3313
Atomic-Resolution Structures of Apc4 and Apc5
Received 9 June 2015; Received in revised form 19 August 2015; Accepted 26 August 2015 Available online 4 September 2015 Keywords: anaphase-promoting complex; ubiquitin; cell cycle; multisubunit structure; protein crystallography
[10]
[11]
[12]
[13]
†N.B.C., J.Y. and Z.Z. contributed equally to this work. ‡pymol.org. §http://babel.ucmp.umu.se/ond-crf/. ||http://toolkit.tuebingen.mpg.de/tprpred. ¶http://toolkit.tuebingen.mpg.de/HHrep. ahttp://www.sbg.bio.ic.ac.uk/phyre2/html/page. cgi?id=index.
[14]
[15]
[16]
Abbreviations used: APC/C, anaphase-promoting complex/cyclosome; cryo-EM, cryo-electron microscopy; EM, electron microscopy; CDK, cyclin-dependent kinase; TPR, tetratricopeptide repeat; SAXS, small-angle X-ray scattering; EDTA, ethylenediaminetetraacetic acid; PEG, polyethylene glycol; Bistris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
References [1] J. Pines, Cubism and the cell cycle: The many faces of the APC/C, Nat. Rev. Mol. Cell Biol. 12 (7) (2011) 427–438. [2] D. Barford, Structural insights into anaphase-promoting complex function and mechanism, Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 (1584) (2011) 3605–3624. [3] I. Primorac, A. Musacchio, Panta rhei: The APC/C at steady state, J. Cell Biol. 201 (2) (2013) 177–189. [4] L. Chang, D. Barford, Insights into the anaphase-promoting complex: A molecular machine that regulates mitosis, Curr. Opin. Struct. Biol. 29 (2014) 1–9. [5] H.J. Meyer, M. Rape, Processive ubiquitin chain formation by the anaphase-promoting complex, Semin. Cell Dev. Biol. 22 (6) (2011) 544–550. [6] Y. Kimata, J.E. Baxter, A.M. Fry, H. Yamano, A role for the fizzy/Cdc20 family of proteins in activation of the APC/C distinct from substrate recruitment, Mol. Cell 32 (4) (2008) 576–583. [7] J.L. Burton, M.J. Solomon, D box and KEN box motifs in budding yeast Hsl1p are required for APC-mediated degradation and direct binding to Cdc20p and Cdh1p, Genes Dev. 15 (18) (2001) 2381–2395. [8] E. Eytan, Y. Moshe, I. Braunstein, A. Hershko, Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding, Proc. Natl. Acad. Sci. U. S. A. 103 (7) (2006) 2081–2086. [9] Z. Hilioti, Y.S. Chung, Y. Mochizuki, C.F. Hardy, O. CohenFix, The anaphase inhibitor Pds1 binds to the APC/C-
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
associated protein Cdc20 in a destruction box-dependent manner, Curr. Biol. 11 (17) (2001) 1347–1352. C. Kraft, H.C. Vodermaier, S. Maurer-Stroh, F. Eisenhaber, J.M. Peters, The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates, Mol. Cell 18 (5) (2005) 543–553. C.M. Pfleger, E. Lee, M.W. Kirschner, Substrate recognition by the Cdc20 and Cdh1 components of the anaphasepromoting complex, Genes Dev. 15 (18) (2001) 2396–2407. M. Schwab, M. Neutzner, D. Mocker, W. Seufert, Yeast Hct1 recognizes the mitotic cyclin Clb2 and other substrates of the ubiquitin ligase APC, EMBO J. 20 (18) (2001) 5165–5175. L. Chang, Z. Zhang, J. Yang, S.H. McLaughlin, D. Barford, Molecular architecture and mechanism of the anaphasepromoting complex, Nature 513 (7518) (2014) 388–393. V.A. Van Voorhis, D.O. Morgan, Activation of the APC/C ubiquitin ligase by enhanced E2 efficiency, Curr. Biol. 24 (13) (2014) 1556–1562. A. Kelly, K.E. Wickliffe, L. Song, I. Fedrigo, M. Rape, Ubiquitin chain elongation requires E3-dependent tracking of the emerging conjugate, Mol. Cell 56 (2) (2014) 232–245. M. Glotzer, A.W. Murray, M.W. Kirschner, Cyclin is degraded by the ubiquitin pathway, Nature 349 (6305) (1991) 132–138. C.M. Pfleger, M.W. Kirschner, The KEN box: An APC recognition signal distinct from the D box targeted by Cdh1, Genes Dev. 14 (6) (2000) 655–665. J. He, W.C. Chao, Z. Zhang, J. Yang, N. Cronin, D. Barford, Insights into degron recognition by APC/C coactivators from the structure of an Acm1-Cdh1 complex, Mol. Cell 50 (5) (2013) 649–660. B. Di Fiore, N.E. Davey, A. Hagting, D. Izawa, J. Mansfeld, T.J. Gibson, J. Pines, The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators, Dev. Cell 32 (3) (2015) 358–372. C.W. Carroll, M. Enquist-Newman, D.O. Morgan, The APC subunit Doc1 promotes recognition of the substrate destruction box, Curr. Biol. 15 (1) (2005) 11–18. P.C. da Fonseca, E.H. Kong, Z. Zhang, A. Schreiber, M.A. Williams, E.P. Morris, D. Barford, Structures of APC/C(Cdh1) with substrates identify Cdh1 and Apc10 as the D-box coreceptor, Nature 470 (7333) (2011) 274–278. A.D. Rudner, A.W. Murray, Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphasepromoting complex, J. Cell Biol. 149 (7) (2000) 1377–1390. E.R. Kramer, N. Scheuringer, A.V. Podtelejnikov, M. Mann, J.M. Peters, Mitotic regulation of the APC activator proteins Cdc20 and Cdh1, Mol. Biol. Cell 11 (5) (2000) 1555–1569. S.L. Jaspersen, J.F. Charles, D.O. Morgan, Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14, Curr. Biol. 9 (5) (1999) 227–236. W. Zachariae, M. Schwab, K. Nasmyth, W. Seufert, Control of cyclin ubiquitination by Cdk-regulated binding of Hct1 to the anaphase promoting complex, Science 282 (5394) (1998) 1721–1724. J.D. Leverson, C.A. Joazeiro, A.M. Page, H. Huang, P. Hieter, T. Hunter, The Apc11 RING-H2 finger mediates E2dependent ubiquitination, Mol. Biol. Cell 11 (7) (2000) 2315–2325. M. Gmachl, C. Gieffers, A.V. Podtelejnikov, M. Mann, J.M. Peters, The RING-H2 finger protein Apc11 and the E2 enzyme Ubc4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex, Proc. Natl. Acad. Sci. U. S. A. 97 (16) (2000) 8973–8978.
3314 [28] Z. Tang, B. Li, R. Bharadwaj, H. Zhu, E. Ozkan, K. Hakala, J. Deisenhofer, H. Yu, Apc2 cullin protein and Apc11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex, Mol. Biol. Cell 12 (12) (2001) 3839–3851. [29] E. Ozkan, H. Yu, J. Deisenhofer, Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases, Proc. Natl. Acad. Sci. U. S. A. 102 (52) (2005) 18890–18895. [30] N.G. Brown, R. VanderLinden, E.R. Watson, R. Qiao, C.R. Grace, M. Yamaguchi, F. Weissmann, J.J. Frye, P. Dube, S. Ei Cho, M.L. Actis, et al., Ring E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex, Proc. Natl. Acad. Sci. U. S. A. 112 (17) (2015) 5272–5279. [31] N.G. Brown, E.R. Watson, F. Weissmann, M.A. Jarvis, R. VanderLinden, C.R. Grace, J.J. Frye, R. Qiao, P. Dube, G. Petzold, S.E. Cho, et al., Mechanism of polyubiquitination by human anaphase-promoting complex: Ring repurposing for ubiquitin chain assembly, Mol. Cell 56 (2) (2014) 246–260. [32] L.A. Passmore, E.A. McCormack, S.W. Au, A. Paul, K.R. Willison, J.W. Harper, D. Barford, Doc1 mediates the activity of the anaphase-promoting complex by contributing to substrate recognition, EMBO J. 22 (4) (2003) 786–796. [33] J. Wang, B.T. Dye, K.R. Rajashankar, I. Kurinov, B.A. Schulman, Insights into anaphase promoting complex TPR subdomain assembly from a CDC26-APC6 structure, Nat. Struct. Mol. Biol. 16 (9) (2009) 987–989. [34] Z. Zhang, L. Chang, J. Yang, N. Conin, K. Kulkarni, D. Barford, The four canonical TPR subunits of human APC/C form related homo-dimeric structures and stack in parallel to form a TPR suprahelix, J. Mol. Biol. 425 (22) (2013) 4236–4248. [35] Z. Zhang, K. Kulkarni, S.J. Hanrahan, A.J. Thompson, D. Barford, The APC/C subunit Cdc16/Cut9 is a contiguous tetratricopeptide repeat superhelix with a homo-dimer interface similar to Cdc27, EMBO J. 29 (21) (2010) 3733–3744. [36] Z. Zhang, S.M. Roe, M. Diogon, E. Kong, H. El Alaoui, D. Barford, Molecular structure of the N-terminal domain of the APC/C subunit Cdc27 reveals a homo-dimeric tetratricopeptide repeat architecture, J. Mol. Biol. 397 (5) (2010) 1316–1328. [37] M. Yamaguchi, S. Yu, R. Qiao, F. Weissmann, D.J. Miller, R. VanderLinden, N.G. Brown, J.J. Frye, J.M. Peters, B.A. Schulman, Structure of an Apc3-Apc16 complex: Insights into assembly of the anaphase-promoting complex/cyclosome, J. Mol. Biol. 427 (8) (2015) 1748–1764. [38] A. Lupas, W. Baumeister, K. Hofmann, A repetitive sequence in subunits of the 26S proteasome and 20S cyclosome (anaphase-promoting complex), Trends Biochem. Sci. 22 (6) (1997) 195–196. [39] J. He, K. Kulkarni, P.C. da Fonseca, D. Krutauz, M.H. Glickman, D. Barford, E.P. Morris, The structure of the 26S proteasome subunit Rpn2 reveals its PC repeat domain as a closed toroid of two concentric alpha-helical rings, Structure 20 (3) (2012) 513–521. [40] A. Schreiber, F. Stengel, Z. Zhang, R.I. Enchev, E.H. Kong, E.P. Morris, C.V. Robinson, P.C. da Fonseca, D. Barford, Structural basis for the subunit assembly of the anaphasepromoting complex, Nature 470 (7333) (2011) 227–232. [41] C. Kraft, F. Herzog, C. Gieffers, K. Mechtler, A. Hagting, J. Pines, J.M. Peters, Mitotic regulation of the human anaphase-promoting complex by phosphorylation, EMBO J. 22 (24) (2003) 6598–6609.
Atomic-Resolution Structures of Apc4 and Apc5
[42] J.A. Steen, H. Steen, A. Georgi, K. Parker, M. Springer, M. Kirchner, F. Hamprecht, M.W. Kirschner, Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: A quantitative proteomic analysis, Proc. Natl. Acad. Sci. U. S. A. 105 (16) (2008) 6069–6074. [43] W. van Zon, J. Ogink, B. ter Riet, R.H. Medema, H. te Riele, R.M. Wolthuis, The APC/C recruits cyclin b1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit, J. Cell Biol. 190 (4) (2010) 587–602. [44] L. Chang, Z. Zhang, J. Yang, S.H. McLaughlin, D. Barford, Atomic structure of the APC/C and its mechanism of protein ubiquitination, Nature 522 (7557) (2015) 450–454. [45] L. Wang, U.H. Sauer, OnD-CRF: Predicting order and disorder in proteins using [corrected] conditional random fields, Bioinformatics 24 (11) (2008) 1401–1402. [46] Z. Yang, K. Lasker, D. Schneidman-Duhovny, B. Webb, C.C. Huang, E.F. Pettersen, T.D. Goddard, E.C. Meng, A. Sali, T.E. Ferrin, UCSF Chimera, MODELLER, and IMP: An integrated modeling system, J. Struct. Biol. 179 (3) (2012) 269–278. [47] L. Holm, S. Kaariainen, P. Rosenstrom, A. Schenkel, Searching protein structure databases with DaliLite v.3, Bioinformatics 24 (23) (2008) 2780–2781. [48] J. Yang, P. Dokurno, N.K. Tonks, D. Barford, Crystal structure of the M-fragment of alpha-catenin: Implications for modulation of cell adhesion, EMBO J. 20 (14) (2001) 3645–3656. [49] A.K. Das, P.W. Cohen, D. Barford, The structure of the tetratricopeptide repeats of protein phosphatase 5: Implications for TPR-mediated protein–protein interactions, EMBO J. 17 (5) (1998) 1192–1199. [50] L.D. D'Andrea, L. Regan, Tpr proteins: The versatile helix, Trends Biochem. Sci. 28 (12) (2003) 655–662. [51] M.R. Karpenahalli, A.N. Lupas, J. Soding, TPRpred: A tool for prediction of TPR-, PPR- and SEL1-like repeats from protein sequences, BMC Bioinf. 8 (2007) 2. [52] A. Biegert, C. Mayer, M. Remmert, J. Soding, A.N. Lupas, The MPI bioinformatics toolkit for protein sequence analysis, Nucleic Acids Res. 34 (Web server issue) (2006) W335–W339. [53] L.A. Kelley, M.J. Sternberg, Protein structure prediction on the Web: A case study using the Phyre server, Nat. Protoc. 4 (3) (2009) 363–371. [54] Z. Zhang, J. Yang, E.H. Kong, W.C. Chao, E.P. Morris, P.C. da Fonseca, D. Barford, Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C), Biochem. J. 449 (2) (2013) 365–371. [55] N. Zheng, B.A. Schulman, L. Song, J.J. Miller, P.D. Jeffrey, P. Wang, C. Chu, D.M. Koepp, S.J. Elledge, M. Pagano, R.C. Conaway, et al., Structure of the Cul1-Rbx1-Skp1-F Box Skp2 SCF ubiquitin ligase complex, Nature 416 (6882) (2002) 703–709. [56] D. Han, K. Kim, Y. Kim, Y. Kang, J.Y. Lee, Y. Kim, Crystal structure of the N-terminal domain of anaphase-promoting complex subunit 7, J. Biol. Chem. 284 (22) (2009) 15137–15146. [57] C.N. Cronin, K.B. Lim, J. Rogers, Production of selenomethionyl-derivatized proteins in baculovirus-infected insect cells, Protein Sci. 16 (9) (2007) 2023–2029. [58] W. Kabsch, Xds, Acta Crystallogr. D Biol. Crystallogr. 66 (Pt 2) (2010) 125–132. [59] Collaborative Computational Project, Number 4, The CCP4 suite: Programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr. 50 (Pt 5) (1994) 760–763.
3315
Atomic-Resolution Structures of Apc4 and Apc5
[60] C. Vonrhein, E. Blanc, P. Roversi, G. Bricogne, Automated structure solution with autoSHARP, Methods Mol. Biol. 364 (2007) 215–230. [61] G.N. Murshudov, P. Skubak, A.A. Lebedev, N.S. Pannu, R.A. Steiner, R.A. Nicholls, M.D. Winn, F. Long, A.A. Vagin, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr. D Biol. Crystallogr. 67 (Pt 4) (2011) 355–367. [62] P. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr. 60 (Pt 12 Pt 1) (2004) 2126–2132. [63] P.D. Adams, R.W. Grosse-Kunstleve, L.W. Hung, T.R. Ioerger, A.J. McCoy, N.W. Moriarty, R.J. Read, J.C. Sacchettini, N.K. Sauter, T.C. Terwilliger, PHENIX: Building new software for automated crystallographic structure determination, Acta Crystallogr. D Biol. Crystallogr. 58 (Pt 11) (2002) 1948–1954. [64] A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, R.J. Read, PHASER crystallographic software, J. Appl. Crystallogr. 40 (2007) 658–674. [65] I.W. Davis, A. Leaver-Fay, V.B. Chen, J.N. Block, G.J. Kapral, X. Wang, L.W. Murray, W.B. Arendall 3rd, J.
[66]
[67]
[68]
[69] [70]
Snoeyink, J.S. Richardson, D.C. Richardson, MolProbity: All-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res. 35 (Web server issue) (2007) W375–W383. M. Landau, I. Mayrose, Y. Rosenberg, F. Glaser, E. Martz, T. Pupko, N. Ben-Tal, ConSurf 2005: The projection of evolutionary conservation scores of residues on protein structures, Nucleic Acids Res. 33 (Web server issue) (2005) W299–W302. D. Schneidman-Duhovny, M. Hammel, A. Sali, FoXS: A Web server for rapid computation and fitting of SAXS profiles, Nucleic Acids Res. 38 (Web server issue) (2010) W540–W544. A. Kucukelbir, F.J. Sigworth, H.D. Tagare, Quantifying the local resolution of cryo-EM density maps, Nat. Methods 11 (1) (2014) 63–65. G.J. Barton, ALSCRIPT: A tool to format multiple sequence alignments, Protein Eng. 6 (1) (1993) 37–40. K.S. Wendt, H.C. Vodermaier, U. Jacob, C. Gieffers, M. Gmachl, J.M. Peters, R. Huber, P. Sondermann, Crystal structure of the Apc10/Doc1 subunit of the human anaphasepromoting complex, Nat. Struct. Biol. 8 (9) (2001) 784–788.
